Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients
NCT04501354
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Mesenchymal Stem Cell
Sponsor
Ahmad Jabir Rahyussalim